Document:

EXHIBIT 10.30

 

IMCLONE SYSTEMS INCORPORATED

 

CHANGE-IN-CONTROL PLAN

 

1.0           PURPOSE
OF PLAN

 

1.1           Purpose.  The purpose of the ImClone Systems
Incorporated Change-in-Control Plan (the “Plan”) is to:

 

(a)           retain
certain highly qualified individuals as employees of ImClone Systems
Incorporated and/or its subsidiaries (the “Company”);

 

(b)           maintain
the focus of such employees on the business of the Company and to mitigate the distractions
caused by the possibility that the Company may be the target of an acquisition strategy;
and

 

(c)           provide
certain benefits to such employees if a change in control of the Company occurs
and/or any employee’s employment is terminated in connection with such change
in control.

 

The Plan is intended to qualify as an “employee
benefit plan” (as such term is defined under Section 3(3) of the
Employee Retirement Income Security Act of 1974, as amended (“ERISA”)) and
accordingly will be subject to ERISA.  In
addition, the Plan is intended to qualify as a “top-hat” plan (as such term is
commonly used under the ERISA regulations promulgated by the U.S. Department of
Labor) since it is intended to provide benefits only to a select group of
management or highly compensated employees of the Company.

 

2.0           DEFINITIONS

 

The
following terms shall have the following meanings unless the context indicates
otherwise:

 

2.1           “Beneficiary” shall mean a beneficiary
designated in writing by a Participant to receive any Change-in-Control
Benefits in accordance with Sections 5 or 6 below.  If no beneficiary is designated by the
Participant, then the Participant’s estate shall be deemed to be the
Participant’s Beneficiary.

 

2.2           “Board” shall mean the Board of Directors of the Company.

 

2.3           “Bonus” shall mean the 3-year average of the actual annual
bonuses paid to the Participant during the 36-month period immediately
preceding the Change-in-Control Date, with such amount increased (if
applicable) to take into account any elective or mandatory deferrals.  For a Participant who has not been employed
by the Company for the full 36-month period prior to the Change-in-Control
Date, the average annual bonus amount shall be calculated based on the number
of full years of employment.  For a
Participant who has not been employed long enough to receive an annual bonus,
the annual bonus amount shall be equal to the target annual bonus.

 

2.4           “Cause” shall mean – unless otherwise defined in an
employment agreement between the Participant and the Company or Subsidiary –
the occurrence of any of the following:

 

(1)           an
indictment of the Participant involving a
felony or a misdemeanor involving moral turpitude; or

 

(2)           willful misconduct or gross negligence by the
Participant resulting, in either case, in harm to the Company or any
Subsidiary; or

 

1

 

(3)           failure by the Participant to carry out the
directions of the Board or the Participant’s immediate supervisor, as the case
may be; or

 

(4)           fraud,
embezzlement, theft or dishonesty by the Participant against the Company or any
Subsidiary or a material violation by the
Participant of a policy or procedure of the Company, resulting, in any case, in
harm to the Company or any Subsidiary.

 

2.5           “Change in Control” shall mean the occurrence of one of the
following events:

 

(1)           individuals
who, on the Effective Date, constitute the Board (the “Incumbent Directors”)
cease for any reason to constitute at least a majority of the Board, provided
that any person becoming a director subsequent to the Effective Date whose
election or nomination for election was approved by a vote of at least
two-thirds of the Incumbent Directors then on the Board (either by a specific
vote or by approval of the proxy statement of the Company in which such person
is named as a nominee for director, without objection to such nomination) shall
be an Incumbent Director; provided, however, that no individual initially
elected or nominated as a director of the Company as a result of an actual or
threatened election contest with respect to directors or as a result of any other
actual or threatened solicitation of proxies by or on behalf of any person
other than the Board shall be an Incumbent Director;

 

(2)           any “person”
(as such term is defined in Section 3(a)(9) of the Securities
Exchange Act of 1934 (the “Exchange Act”) and as used in Sections 13(d)(3) and
14(d)(2) of the Exchange Act) is or becomes, after the Effective Date, a “beneficial
owner” (as defined in Rule 13d-3 under the Exchange Act), directly or
indirectly, of securities of the Company representing 40% or more of the
combined voting power of the Company’s then outstanding securities eligible to
vote for the election of the Board (the “Company Voting Securities”); provided,
however, that an event described in this Section 2.5(2) shall not be
deemed to be a Change in Control if any of following becomes such a beneficial
owner:

 

(A)          the Company
or any majority-owned subsidiary (provided, that this exclusion applies solely
to the ownership levels of the Company or the majority-owned subsidiary),

 

(B)           any
tax-qualified, broad-based employee benefit plan sponsored or maintained by the
Company or any majority-owned subsidiary,

 

(C)           any
underwriter temporarily holding securities pursuant to an offering of such securities,
or

 

(D)          any person
pursuant to a Non-Qualifying Transaction (as defined in Section 2.5(3) below);

 

(3)           the
consummation of a merger, consolidation, statutory share exchange or similar
form of corporate transaction involving the Company or any of its Subsidiaries
that requires the approval of the Company’s stockholders, whether for such
transaction or the issuance of securities in the transaction (a “Business
Combination”), unless immediately following such Business Combination:

 

(A)          50% or more
of the total voting power of:

 

(x)            the
corporation resulting from such Business Combination (the “Surviving Corporation”),
or

 

2

 

(y)           if
applicable, the ultimate parent corporation that directly or indirectly has beneficial
ownership of 100% of the voting securities eligible to elect directors of the Surviving Corporation (the “Parent
Corporation”),

 

is represented by
Company Voting Securities that were outstanding immediately prior to such
Business Combination (or, if applicable, is represented by shares into which
such Company Voting Securities were converted pursuant to such Business
Combination), and such voting power among the holders thereof is in substantially
the same proportion as the voting power of such Company Voting Securities among
the holders thereof immediately prior to the Business Combination;

 

(B)           no
person (other than any employee benefit plan (or related trust) sponsored or maintained
by the Surviving Corporation or the Parent Corporation), is or becomes the
beneficial owner, directly or indirectly, of 40% or more of the total voting
power of the outstanding voting securities eligible to elect directors of the Parent
Corporation (or, if there is no Parent Corporation, the Surviving Corporation);
and

 

(C)           at
least a majority of the members of the board of directors of the Parent Corporation
(or if there is no Parent Corporation, the Surviving Corporation) following the
consummation of the Business Combination were Incumbent Directors at the time
of the Board’s approval of the execution of the initial agreement providing for
such Business Combination

 

(any
Business Combination which satisfies all of the criteria specified in (A), (B) and
(C) above shall be deemed to be a “Non-Qualifying Transaction”); or

 

(4)           stockholder
approval of a liquidation or dissolution of the Company, unless the voting
common equity interests of an ongoing entity (other than a liquidating trust)
are beneficially owned, directly or indirectly, by the Company’s shareholders
in substantially the same proportions as such shareholders owned the Company’s
outstanding voting common equity interests immediately prior to such
liquidation and such ongoing entity assumes all existing obligations of the
Company under this Plan.

 

Notwithstanding the foregoing, a Change in Control of
the Company shall not be deemed to occur solely because any person acquires
beneficial ownership of more than 40% of the Company Voting Securities as a
result of the acquisition of Company Voting Securities by the Company which
reduces the number of Company Voting Securities outstanding; provided, that, if
after such acquisition by the Company such person becomes the beneficial owner
of Company Voting Securities that increases the percentage of outstanding
Company Voting Securities beneficially owned by such person, a Change in
Control of the Company shall then occur.

 

2.6           “Change-in-Control Benefits” shall mean the benefits
described in Sections 5 and 6 below.

 

2.7           “Change-in-Control Date” shall mean the date that a Change
in Control first occurs.

 

2.8           “Change-in-Control Termination” shall mean a termination of
the Participant’s employment:

 

(1)           by the
Company without Cause during the period beginning 3 months prior to the
Change-in-Control Date and ending 18 months after the Change-in-Control Date,
or

 

(2)           if the
Participant has been designated by the Committee as a Tier 1 Participant or a
Tier 2 Participant in accordance with Section 3.2 below, by the
Participant for Good Reason during the period beginning 3 months prior to the
date of the Change in Control and ending 18 months after the Change-in-Control
Date.

 

3

 

2.9           “Code” shall mean the Internal Revenue Code of
1986, as amended from time to time.

 

2.10         “Committee” shall mean (i) the Board or (ii) a
committee or subcommittee of the Board appointed by the Board from among its
members.  The Committee may be the Board’s
compensation committee.

 

2.11         “Company” shall mean ImClone Systems Incorporated, a
Delaware corporation, including any successor entity or any successor to the assets
of the Company that has assumed the Plan.

 

2.12         “Competitive
Activity” shall mean the Participant’s engaging in an
activity – whether as an employee, consultant, principal, member, agent,
officer, director, partner or shareholder (except as a less than 1% shareholder
of a publicly traded company) – that is competitive with any business of the
Company or any Subsidiary conducted by the Company or such Subsidiary at any
time during the Noncompetition/Nonsolicitation Period; provided, however, that the Participant
may be employed by or otherwise associated with:

 

(i)            a
business of which a subsidiary, division, segment, unit, etc. is in competition
with the Company or any Subsidiary but as to which such subsidiary, division, segment,
unit, etc. the Participant has absolutely no direct or indirect responsibilities
or involvement, or

 

(ii)           a company where the Competitive Activity is:

 

(A)          from the perspective of such company, de minimis with respect to the business of
such company and its affiliates, and

 

(B)           from the perspective of the Company or any
Subsidiary, not in material competition with the Company or any Subsidiary.

 

2.13         “Effective Date” shall mean the date the Board adopts the
Plan.

 

2.14         “Employee” shall mean a regular full-time employee of the Company
or any Subsidiary.

 

2.15         “Good Reason” shall mean – unless otherwise defined in an
employment agreement between the Participant and the Company or Subsidiary –
the occurrence of any of the following within the 60-day period preceding a
Termination Date:

 

(1)           a material adverse diminution of the Participant’s
titles, authority, duties or responsibilities, or the assignment to the
Participant of titles, authority, duties or responsibilities that are
materially inconsistent with his or her titles, authority, duties and/or
responsibilities in a manner materially adverse to the Participant; or

 

(2)           a
reduction in the Participant’s base salary, annual target bonus, or maximum
bonus without the Participant’s prior written consent (other than any reduction
applicable to Employees generally); or

 

(3)           an actual
change in the Participant’s principal work location by more than 75 miles and
more than 75 miles from the Participant’s principal place of abode as of the
date of such change in job location without the Participant’s prior written
consent; or

 

(4)           a failure
of the Company to obtain the assumption in writing of its obligation under the
Plan by any successor to all or substantially all of the assets of the Company
within 45 days after a merger, consolidation, sale or similar transaction that
qualifies as a Change in Control.

 

4

 

2.16         “Health Continuation Period” shall mean the period
commencing on the Termination Date and continuing until the end of the applicable
period as shown on Schedule A..

 

2.17         “Noncompetition/Nonsolicitation
Period” shall mean the period commencing on the Termination Date and
continuing until the end of the applicable period as shown on Schedule A.

 

2.18         “Participant” shall mean any Employee who has been
designated to participate in the Plan under Section 3 below.

 

2.19         “Plan” shall mean the ImClone Systems Incorporated
Change-in-Control Plan.

 

2.20         “Salary” shall mean the highest annual base salary paid to
the Participant during the 12-month period immediately preceding the earlier of
(i) the Termination Date or the Change-in-Control Date, with such amount
increased (if applicable) to take into account any elective or mandatory
deferrals.

 

2.21         “Severance Multiplier” shall mean the multiplier that shall
be used to determine cash severance paid to a Participant in accordance with Schedule A
and Section 6.2 below.

 

2.22         “Subsidiary” shall mean a corporation of which the Company
directly or indirectly owns more than 50 percent of the “voting stock” (meaning
the capital stock of any class or classes having general voting power under
ordinary circumstances, in the absence of contingencies, to elect the directors
of a corporation) or any other business entity in which the Company directly or
indirectly has an ownership interest of more than 50 percent.

 

2.23         “Terminated Participant” shall mean a Participant whose
employment with the Company and/or a Subsidiary has been terminated and which
qualifies as a Change-in-Control Termination.

 

2.24         “Termination Date” shall mean the date a Terminated
Participant’s employment with the Company and/or a Subsidiary is terminated.

 

2.25         “Tier 1 Participant” shall mean a Participant who has been
designated by the Committee as a Tier 1 Participant in accordance with Section 3.2
below.

 

2.26         “Tier 2 Participant” shall mean a Participant who has been
designated by the Committee as a Tier 2 Participant in accordance with Section 3.2
below.

 

2.27         “Tier 3 Participant” shall mean a Participant who has been
designated by the Committee as a Tier 3 Participant in accordance with Section 3.2
below.

 

2.28         “Tier 4 Participant” shall mean a Participant who has been
designated by the Committee as a Tier 4 Participant in accordance with Section 3.2
below.

 

3.0           ELIGIBILITY
AND PARTICIPATION

 

3.1           Eligibility.  All Employees of the Company shall be
eligible to participate in the Plan.

 

3.2           Participation.  Participants shall consist of such Employees
as the Committee in its sole discretion designates to participate in the Plan; provided, however, that the Committee shall not designate an
Employee as a new Participant following a Change-in-Control Date.  At the time the Committee designates an
Employee as a Participant, the Committee shall also designate whether such
Employee is a Tier 1 Participant, a Tier 2 Participant, a Tier 3 Participant or
a Tier 4 Participant.  The Committee may,
in its sole discretion, terminate a Participant’s participation in the Plan at
any time prior to the beginning of the 180-day period ending on the Change-in-Control
Date.

 

5

 

4.0           ADMINISTRATION

 

4.1           Responsibility.  The Committee shall have the responsibility,
in its sole discretion, to control, operate, manage and administer the Plan in
accordance with its terms.

 

4.2           Authority of the
Committee.  The Committee shall have
the maximum discretionary authority permitted by law that may be necessary to
enable it to discharge its responsibilities with respect to the Plan, including
but not limited to the following:

 

(a)           to
determine eligibility for participation in the Plan;

 

(b)           to
designate Participants;

 

(c)           to
determine and establish the formula to be used in calculating a Participant’s
Change-in-Control Benefits;

 

(d)           to correct
any defect, supply any omission, or reconcile any inconsistency in the Plan in
such manner and to such extent as it shall deem appropriate in its sole
discretion to carry the same into effect;

 

(e)           to issue
administrative guidelines as an aid to administer the Plan and make changes in
such guidelines as it from time to time deems proper;

 

(f)            to make rules for
carrying out and administering the Plan and make changes in such rules as
it from time to time deems proper;

 

(g)           to the
extent permitted under the Plan, grant waivers of Plan terms, conditions,
restrictions, and limitations;

 

(h)           to make
reasonable determinations as to a Participant’s eligibility for benefits under
the Plan, including determinations as to Cause and Good Reason; and

 

(i)            to take
any and all other actions it deems necessary or advisable for the proper
operation or administration of the Plan.

 

4.3           Action by the Committee.  The Committee may act only by a majority of
its members.  Any determination of the
Committee may be made, without a meeting, by a writing or writings signed by
all of the members of the Committee.  In
addition, the Committee may authorize any one or more of its members to execute
and deliver documents on behalf of the Committee.

 

4.4           Delegation of Authority.  The Committee may delegate to one or more of its
members, or to one or more agents, such administrative duties as it may deem
advisable; provided, however, that any such
delegation shall be in writing.  In
addition, the Committee, or any person to whom it has delegated duties as
aforesaid, may employ one or more persons to render advice with respect to any
responsibility the Committee or such person may have under the Plan.  The Committee may employ such legal or other
counsel, consultants and agents as it may deem desirable for the administration
of the Plan and may rely upon any opinion or computation received from any such
counsel, consultant or agent.  Expenses
incurred by the Committee in the engagement of such counsel, consultant or
agent shall be paid by the Company, or the Subsidiary whose employees have
benefited from the Plan, as determined by the Committee.

 

4.5           Determinations and
Interpretations by the Committee. 
All determinations and interpretations made by the Committee shall be
binding and conclusive to the maximum extent permitted by law on all
Participants and their heirs, successors, and legal representatives.

 

6

 

4.6           Information.  The Company shall furnish to the Committee in
writing all information the Committee may deem appropriate for the exercise of
its powers and duties in the administration of the Plan.  Such information may include, but shall not
be limited to, the full names of all Participants, their earnings and their
dates of birth, employment, retirement or death.  Such information shall be conclusive for all
purposes of the Plan, and the Committee shall be entitled to rely thereon
without any investigation thereof.

 

4.7           Self-Interest.  No member of the Committee may act, vote or
otherwise influence a decision of the Committee specifically relating to his or
her benefits, if any, under the Plan.

 

4.8           Liability.  No
member of the Board, no member of the Committee and no employee of the Company
shall be liable for any act or failure to act hereunder, except in
circumstances involving his or her bad faith, gross negligence or willful
misconduct, or for any act or failure to act hereunder by any other member or
employee or by any agent to whom duties in connection with the administration
of the Plan have been delegated.

 

4.9           Indemnification.  The
Company shall indemnify members of the Committee and any agent of the Committee
who is an employee of the Company, against any and all liabilities or expenses
to which they may be subjected by reason of any act or failure to act with
respect to their duties on behalf of the Plan, except in circumstances
involving such person’s bad faith, gross negligence or willful misconduct.

 

5.0           SINGLE-TRIGGER
BENEFITS

 

5.1           Equity-Based
Compensation.  Unless otherwise
provided in any written agreement between the Company and a Participant, all
equity-based compensation awards held by the Participants as of the
Change-in-Control Date shall become fully vested and/or exercisable as of such
date, unless the Committee, in its sole discretion, determines (i) that
such awards will be substituted, replaced, rolled over, or converted into
equity-based compensation awards of the acquiring and/or surviving entity and (ii) the
economic value and benefit of the equity-based compensation awards immediately
prior to the Change-in-Control Date are equal to the economic value and benefit
of the equity-based compensation awards immediately after the Change-in-Control
Date, on an award-by-award basis.

 

5.2           Deferred Compensation. 
Unless otherwise provided in any written agreement between the Company
and a Participant, a Participant’s unvested nonqualified deferred compensation
as of the Change-in-Control Date shall become fully vested and nonforfeitable
as of such date.

 

5.3           Payment of
Change-in-Control Benefits to Beneficiaries.  In the event of the Participant’s death, all
Change-in-Control Benefits that would have been paid to the Participant under
this Section 5 but for his or her death, shall be paid to the Participant’s
Beneficiary.

 

5.4           Other Benefits.  Notwithstanding anything contained in the
Plan to the contrary, the Company or the Committee may, in its sole discretion,
provide benefits in addition to the benefits described under this Section 5.

 

6.0           DOUBLE-TRIGGER
BENEFITS

 

6.1           Accrued Obligations.  Unless otherwise provided in any written
agreement between the Company and the Participant, on the later to occur of (i) a
Change-in-Control Date or (ii) a Termination Date, the Company shall pay
to the Terminated Participant during the 30-day period following the later of (x)
the Change-in-Control Date or (y) the Termination Date, a lump sum cash payment
equal to the Participant’s earned but unpaid Salary and/or Bonus, plus
unreimbursed expenses, plus any and all other Company obligations that are
accrued and due and owing to the Terminated Participant.

 

7

 

6.2           Cash Severance.  Unless otherwise provided in any written
agreement between the Company and the Participant, on the later to occur of (i) a
Change-in-Control Date or (ii) a Termination Date, the Company shall pay
to the Terminated Participant during the 30-day period following the later of
(x) the Change-in-Control Date or (y) the Termination Date, a lump sum cash
payment equal to the sum of:

 

(A)          a pro rata
annual target bonus with respect to the year that the Termination Date occurs, plus

 

(B)           the
product of (x) the Severance Multiplier times (y) the sum of the Terminated
Participant’s (a) Salary plus (b) Bonus.

 

6.3           Long-Term Incentive
Compensation.  Unless otherwise provided
in any written agreement between the Company and a Participant, any and all
long-term incentive arrangements that did not vest and/or become payable in
accordance with Section 5 above shall be paid to the Participant in
accordance with the terms and conditions of such long-term incentive
arrangement, or if such arrangement does not provide express terms and
conditions relating to the consequences of a Change in Control, then:

 

(a)           all
equity-based compensation awards held by the Terminated Participant as of the Termination
Date shall become fully vested and/or exercisable as of such date, and

 

(b)           awards
under any long-term incentive arrangement shall be paid to the Terminated Participant
based on a pro rata portion of the completed performance cycle or vesting period,
as applicable, as of the Termination Date and using actual performance as of
the Termination Date (as applicable).

 

6.4           Pension-Benefit
Arrangements.  Unless otherwise
provided in any written agreement between the Company and a Participant,
benefits under all nonqualified pension-benefit arrangements, including
nonqualified deferred compensation arrangements, may not be paid to the
Terminated Participant prior to the first anniversary of the Change-in-Control
Date.  Notwithstanding the preceding
sentence, the Committee may accelerate such payment, in its sole discretion,
after having received advice from the Company’s tax counsel.

 

6.5           Welfare-Benefit
Arrangements.  Unless otherwise
provided in any written agreement between the Company and a Participant, the
Company shall provide a Terminated Participant with continued health coverage
during the Health Continuation Period as shown on Schedule A.  Unless otherwise provided for in any written
agreement between the Company and a Terminated Participant, or as otherwise
agreed to by the Committee in its sole discretion, all other welfare benefits
shall cease as of the Termination Date. 
Following the end of the applicable Health Continuation Period, the Terminated
Participant shall be eligible to receive COBRA health continuation coverage in
accordance with rules and provisions under the Consolidated Omnibus Budget
Reconciliation Act of 1985.

 

6.6           Outplacement Services.  The Company shall provide a Terminated
Participant with outplacement services during the 6-month period following the
Termination Date.

 

6.7           Payment of
Change-in-Control Benefits to Beneficiaries.  In the event of the Terminated Participant’s
death, all Change-in-Control Benefits that would have been paid to the
Terminated Participant under this Section 6 but for his or her death,
shall be paid to the Terminated Participant’s Beneficiary.

 

6.8           Other Benefits.  Notwithstanding anything contained in the
Plan to the contrary, the Company or the Committee may, in its sole discretion,
provide benefits in addition to the benefits described under this Section 6.

 

8

 

7.0           PARTICIPANT
OBLIGATIONS

 

7.1           Waiver and Release. 
As a condition precedent for receiving the double-trigger benefits
provided under Section 6 above, a Terminated Participant shall execute a
waiver and release substantially in the form attached to the Plan as Exhibit B.

 

7.2           Noncompetition. 
During the Noncompetition/Nonsolicitation Period, a Terminated
Participant shall not at any time, directly or indirectly, engage in
Competitive Activity.

 

7.3           Nonsolicitation. 
During the Noncompetition/Nonsolicitation Period, a Terminated
Participant shall not at any time, directly or indirectly, solicit (x) any
customer or client of the Company or any Subsidiary with respect to a
Competitive Activity or (y) any employee of the Company or any Subsidiary for
the purpose of causing such employee to terminate his or her employment with
the Company or such Subsidiary.

 

7.4           Enforcement.  If a
Terminated Participant violates or threatens to violate Section 7.2 or Section 7.3
above, the Company shall not have an adequate remedy at law.  Accordingly, the Company shall be entitled to
such equitable and injunctive relief as may be available to restrain the
Terminated Participant and any business, firm, partnership, individual,
corporation or entity participating in the breach or threatened breach from the
violation of the provisions of Section 7.2 or 7.3 above.  Nothing in the Plan shall be construed as prohibiting
the Company from pursuing any other remedies available at law or in equity for
breach or threatened breach of Section 7.2 or 7.3 above, including the
recovery of damages.

 

7.5           Confidentiality.  At
all times prior to and after the Change-in-Control Date, a Participant shall
not disclose to anyone or make use of any trade secret or proprietary or
confidential information of the Company, including such trade secret or
proprietary or confidential information of any customer or other entity to
which the Company owes an obligation not to disclose such information, which he
or she acquires during his or her employment with the Company, including but
not limited to records kept in the ordinary course of business, except:

 

(i)            as such
disclosure or use may be required or appropriate in connection with his or her
work as an employee of the Company;

 

(ii)           when
required to do so by a court of law, by any governmental agency having supervisory
authority over the business of the Company or by any administrative or
legislative body (including a committee thereof) with apparent jurisdiction to order
him or her to divulge, disclose or make accessible such information;

 

(iii)          as
to such confidential information that becomes generally known to the public or trade
without his or her violation of this Section 7.5; or

 

(iv)          to the Participant’s spouse and/or his or her
personal tax and financial advisors as reasonably necessary or appropriate to
advance the Participant’s tax,
financial and other personal planning (each an “Exempt Person”), provided, however, that any disclosure or
use of any trade secret or proprietary or confidential information of
the Company by an Exempt Person shall be deemed to be a breach of this Section 7.5
by the Participant.

 

7.6           Return of Company Property. 
Immediately following the Termination Date, a Participant shall
immediately return all Company property in his or her possession, including but
not limited to all computer equipment (hardware and software), telephones,
facsimile machines, palm pilots and other communication devices, credit cards,
office keys, security access cards, badges, identification cards and all copies
(including drafts) of any documentation or information (however stored)
relating to the business of the Company, its customers and clients or its
prospective customers and clients.

 

9

 

7.7           Cooperation. 
Following the Termination Date, a Participant shall give his or her
assistance and cooperation willingly, upon reasonable advance notice with due
consideration for his or her other business or personal commitments, in any
matter relating to his or her position with the Company, or his or her
expertise or experience as the Company may reasonably request, including his or
her attendance and truthful testimony where deemed appropriate by the Company,
with respect to any investigation or the Company’s defense or prosecution of
any existing or future claims or litigations or other proceeding relating to
matters in which he or she was involved or potentially had knowledge by virtue
of his or her employment with the Company. 
In no event shall his or her cooperation materially interfere with his
or her services for a subsequent employer or other similar service
recipient.  The Company agrees that (i) it
will promptly reimburse the Terminated Participant for his or her reasonable
and documented expenses in connection with his or her rendering assistance
and/or cooperation under this Section 7.7, upon his or her presentation of
documentation for such expenses and (ii) the Terminated Participant will
be reasonably compensated for any continued material services as required under
this Section 7.7.

 

8.0           CLAIMS

 

8.1           Claims Procedure.  If any Participant or Beneficiary, or his or
her legal representative, has a claim for benefits which is not being paid,
such claimant may file a written claim with the Committee setting forth the
amount and nature of the claim, supporting facts, and the claimant’s
address.  Written notice of the
disposition of a claim by the Committee shall be furnished to the claimant
within 90 days after the claim is filed. 
In the event of special circumstances, the Committee may extend the
period for determination for up to an additional 90 days, in which case it
shall so advise the claimant.  If the
claim is denied, the reasons for the denial shall be specifically set forth in
writing, pertinent provisions of the Plan shall be cited, including an
explanation of the Plan’s claim review procedure, and, if the claim is
perfectible, an explanation as to how the claimant can perfect the claim shall
be provided.

 

8.2           Claims Review Procedure.  If a claimant whose claim has been denied
wishes further consideration of his or her claim, he or she may request the
Committee to review his or her claim in a written statement of the claimant’s
position filed with the Committee no later than 60 days after receipt of the
written notification provided for in Section 8.1 above.  The Committee shall fully and fairly review
the matter and shall promptly advise the claimant, in writing, of its decision
within the next 60 days.  Due to special
circumstances, the Committee may extend the period for determination for up to
an additional 60 days.

 

8.3           Dispute Resolution.  Any disputes arising under or in connection
with the Plan shall be resolved by binding arbitration, to be held in New York
City in accordance with the rules and procedures of the American
Arbitration Association.  Judgment upon
the award rendered by the arbitrator may be entered in any court having
jurisdiction thereof.

 

8.4           Reimbursement of
Expenses.  If there is any dispute
between the Company and a Participant with respect to a claim under the Plan,
the Company shall reimburse such Participant all reasonable fees, costs and
expenses incurred by such Participant with respect to such disputed claim; provided, however, that (i) such Participant is the
prevailing party with respect to such disputed claim or (ii) the disputed
claim is settled.

 

9.0           TAXES

 

9.1           Withholding Taxes.  The Company shall be entitled to withhold
from any and all payments made to a Participant under the Plan all federal,
state, local and/or other taxes or imposts which the Company determines are
required to be so withheld from such payments or by reason of any other payments
made to or on behalf of the Participant or for his or her benefit hereunder.

 

10

 

9.2           Golden Parachute Excise
Tax Gross-Up.  In the event that a
Participant becomes subject to the excise
tax imposed by Code Section 4999 (the “Parachute Excise Tax”), then the
Company and the Participant shall carry out the following:

 

(a)           if the aggregate “parachute payment” (as such term
is used under Code Section 280G) exceeds 299.99% of the “base amount” (as
such term is used under Code Section 280G) (the “Safe Harbor Amount”) by
less than 10% of the Safe Harbor Amount, then the parachute payment shall be
reduced to the Safe Harbor Amount, with the Participant determining in his or
her sole discretion which portion of the aggregate parachute payment shall be
so reduced; or

 

(b)           if the aggregate parachute payment exceeds the
Safe Harbor Amount by 10% or more of the Safe Harbor Amount, then the Company
shall pay to the Participant a tax gross-up payment so that after
payment by the Participant of all federal, state, and local excise, income,
employment, Medicare and any other taxes (including any related penalties and
interest) resulting from the payment of the parachute payments and the tax
gross-up payments to the Participant by the Company, the Participant retains on
an after-tax basis an amount equal to the amount that the Participant would
have retained had he or she not been subject to the Parachute Excise Tax.

 

9.3           No Guarantee of Tax
Consequences.  No person connected
with the Plan in any capacity, including, but not limited to, the Company and
any Subsidiary and their directors, officers, agents and employees makes any
representation, commitment, or guarantee that any tax treatment, including, but
not limited to, federal, state and local income, estate and gift tax treatment,
will be applicable with respect to amounts deferred under the Plan, or paid to
or for the benefit of a Participant under the Plan, or that such tax treatment
will apply to or be available to a Participant on account of participation in
the Plan.

 

10.0         TERM OF PLAN; AMENDMENT AND TERMINATION OF PLAN

 

10.1         Term of Plan.  The Plan shall be effective as of the
Effective Date and shall remain in effect until the Board terminates the Plan.

 

10.2         Amendment of Plan.  The Plan may be amended by the Board at any
time with or without prior notice; provided, however,
that the Plan shall not be amended on a Change-in-Control Date or during the
3-year period following such Change-in-Control Date.

 

10.3         Termination of Plan. 
The Plan may be terminated or suspended by the Board at any time with or
without prior notice; provided, however,
that the Plan shall not be terminated or suspended on a Change-in-Control Date
or during the 3-year period following such Change-in-Control Date.

 

10.4         No Adverse Effect.  If
the Plan is amended, terminated, or suspended in accordance with Sections 10.2
or 10.3 above, such action shall not adversely affect the benefits of any
Participant.

 

11.0         MISCELLANEOUS

 

11.1         Offset.  Change-in-Control Benefits shall be reduced
by any payment or benefit made or provided by the Company or any Subsidiary to
the Participant pursuant to (i) any severance plan, program, policy or
arrangement of the Company or any Subsidiary not otherwise referred to in the
Plan, (ii) any employment agreement between the Company or any Subsidiary
and the Participant, and (iii) any federal, state or local statute, rule,
regulation or ordinance.

 

11.2         No Right, Title, or
Interest in Company Assets. 
Participants shall have no right, title, or interest whatsoever in or to
any assets of the Company or any investments which the Company may make to aid
it in meeting its obligations under the Plan. 
Nothing contained in the Plan, and no action taken pursuant to its
provisions, shall create or be construed to create a trust of any kind, or a

 

11

 

fiduciary
relationship between the Company and any Participant, Beneficiary, legal
representative or any other person.  To
the extent that any person acquires a right to receive payments from the
Company under the Plan, such right shall be no greater than the right of an
unsecured general creditor of the Company. 
Subject to this Section 11.2, all payments to be made hereunder
shall be paid from the general funds of the Company and no special or separate
fund shall be established and no segregation of assets shall be made to assure
payment of such amounts; provided, however,
that the Company may establish a
grantor trust to provide for the payment of the benefits under the Plan of
which the Company is the grantor within the meaning of subpart E, part I,
subchapter J, chapter 1, subtitle A of the Code and under which the assets held
by such trust will be subject to the claims of the Company’s general creditors
under federal and state law in the event of the Company’s insolvency.

 

11.3         No Right to Continued
Employment.  The Participant’s
rights, if any, to continue to serve the Company as an employee shall not be
enlarged or otherwise affected by his or her designation as a Participant under
the Plan, and the Company or the applicable Subsidiary reserves the right to
terminate the employment of any employee at any time.  The adoption of the Plan shall not be deemed
to give any employee, or any other individual any right to be selected as a
Participant or to continued employment with the Company or any Subsidiary.

 

11.4         Other Rights.  The Plan shall not affect or impair the
rights or obligations of the Company or a Participant under any other written
plan, contract, arrangement, or pension, profit sharing or other compensation
plan.

 

11.5         Governing Law.  The Plan shall be governed by and construed
in accordance with the laws of the State of Delaware without reference to
principles of conflict of laws, except as superseded by ERISA and other
applicable federal law.

 

11.6         Severability.  If any term or condition of the Plan shall be
invalid or unenforceable to any extent or in any application, then the
remainder of the Plan, with the exception of such invalid or unenforceable
provision, shall not be affected thereby and shall continue in effect and
application to its fullest extent.

 

11.7         Incapacity.  If the Committee determines that a
Participant or a Beneficiary is unable to care for his or her affairs because
of illness or accident or because he or she is a minor, any benefit due the
Participant or Beneficiary may be paid to the Participant’s spouse or to any
other person deemed by the Committee to have incurred expense for such
Participant (including a duly appointed guardian, committee or other legal
representative), and any such payment shall be a complete discharge of the
Company’s obligation hereunder.

 

11.8         Transferability of
Rights.  The Company shall have the
unrestricted right to transfer its obligations under the Plan with respect to
one or more Participants to any person, including, but not limited to, any
purchaser of all or any part of the Company’s business.  No Participant or Beneficiary shall have any
right to commute, encumber, transfer or otherwise dispose of or alienate any
present or future right or expectancy which the Participant or Beneficiary may
have at any time to receive payments of benefits hereunder, which benefits and
the right thereto are expressly declared to be non-assignable and
nontransferable, except to the extent required by law.  Any attempt to transfer or assign a benefit,
or any rights granted hereunder, by a Participant or the spouse of a
Participant shall, in the sole discretion of the Committee (after consideration
of such facts as it deems pertinent), be grounds for terminating any rights of
the Participant or Beneficiary to any portion of the Plan benefits not
previously paid.

 

[REMAINDER OF PAGE INTENTIONALLY
LEFT BLANK]

 

12

 

SCHEDULE A

 

	
  TIER

  	
   

  	
  SEVERANCE

  MULTIPLIER

  	
   

  	
  HEALTH CONTINUATION

  PERIOD

  	
   

  	
  NONCOMPETITION /

  NONSOLICITATION PERIOD

  
	
  1

  	
   

  	
  3x

  	
   

  	
  18 months

  	
   

  	
  12 months

  
	
  2

  	
   

  	
  2x

  	
   

  	
  18 months

  	
   

  	
  12 months

  
	
  3

  	
   

  	
  1x

  	
   

  	
  12 months

  	
   

  	
  12 months

  
	
  4

  	
   

  	
  0.5x

  	
   

  	
  6 months

  	
   

  	
  6 months

  

 

13

 

EXHIBIT B

 

RELEASE

 

This
RELEASE (“Release”) dated as of this            day
of
                    ,
20   between ImClone Systems Incorporated, a Delaware
corporation (the “Company”), and
                    
(the “Employee”).

 

WHEREAS,
the Employee is a participant in the Company’s Change-in-Control Plan (the “Plan”);
and

 

WHEREAS,
the Employee’s employment with the Company (has been) (will be) terminated
effective
                            ;
and

 

WHEREAS,
pursuant to Section 7.1 of the Plan, the Employee is entitled to certain
compensation and benefits upon such termination, contingent upon the execution
of this Release;

 

NOW,
THEREFORE, in consideration of the premises and mutual agreements contained
herein and in the Plan, the Company and the Employee agree as follows:

 

1.             The
Employee, on [his/her] own behalf and on behalf of [his/her] heirs, estate and
beneficiaries, does hereby release the Company, and any of its Subsidiaries or
affiliates, and each past or present officer, director, agent, employee,
shareholder, and insurer of any such entities, from any and all claims made, to
be made, or which might have been made of whatever nature, whether known or
unknown, from the beginning of time, including those that arose as a
consequence of [his/her] employment with the Company, or arising out of the
severance of such employment relationship, or arising out of any act committed
or omitted during or after the existence of such employment relationship, all
up through and including the date on which this Release is executed, including,
but not limited to, those which were, could have been or could be the subject
of an administrative or judicial proceeding filed by the Employee or on
[his/her] behalf under federal, state or local law, whether by statute,
regulation, in contract or tort, and including, but not limited to, every claim
for front pay, back pay, wages, bonus, fringe benefit, any form of
discrimination (including but not limited to, every claim of race, color, sex,
religion, national origin, disability or age discrimination), wrongful
termination, emotional distress, pain and suffering, breach of contract,
compensatory or punitive damages, interest, attorney’s fees, reinstatement or
reemployment.  If any court rules that
such waiver of rights to file, or have filed on [his/her] behalf, any
administrative or judicial charges or complaints is ineffective, the Employee
agrees not to seek or accept any money damages or any other relief upon the
filing of any such administrative or judicial charges or complaints.  The Employee relinquishes any right to future
employment with the Company and the Company shall have the right to refuse to
re-employ the Employee without liability. 
The Employee acknowledges and agrees that even though claims and facts
in addition to those now known or believed by [him/her] to exist may
subsequently be discovered, it is [his/her] intention to fully settle and
release all claims [he/she] may have against the Company and the persons and
entities described above, whether known, unknown or suspected.

 

2.             The
Employee acknowledges that [he/she] has been provided at least 21 days to
review the Release and has been advised to review it with an attorney of
[his/her] choice.  In the event the
Employee elects to sign this Release prior to the end of this 21-day period,
[he/she] agrees that it is a knowing and voluntary waiver of [his/her] right to
wait the full 21 days.  The Employee
further understands that [he/she] has 7 days after the signing hereof to revoke
it by so notifying the Company in writing, such notice to be received by
                     
within the 7-day period.  The Employee
further acknowledges that [he/she] has carefully read this Release, and knows
and understands its contents and its binding legal effect.  The Employee acknowledges that by signing
this Release, [he/she] does so of [his/her] own free will and act and that it
is [his/her] intention that [he/she] be legally bound by its terms.

 

14

 

IN
WITNESS WHEREOF, the parties have executed this Release on the date first above
written.

 

 

	
   

  	
  IMCLONE SYSTEMS
  INCORPORATED

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  
	
   

  	
   

  	
  Name:

  
	
   

  	
   

  	
  Title:

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  [Employee’s Name]

  
				

 

 

* * END * *

 

15Exhibit 4.6

 

THIS GLOBAL NOTE IS HELD BY THE DEPOSITARY (AS DEFINED IN THE INDENTURE
GOVERNING THIS NOTE) OR ITS NOMINEE IN CUSTODY FOR THE BENEFIT OF THE
BENEFICIAL OWNERS HEREOF, AND IS NOT TRANSFERABLE TO ANY PERSON UNDER ANY
CIRCUMSTANCES EXCEPT THAT (I) THE TRUSTEE MAY MAKE SUCH NOTATIONS HEREON AS MAY
BE REQUIRED PURSUANT TO SECTION 2.06 OF THE INDENTURE, (II) THIS GLOBAL
NOTE MAY BE EXCHANGED IN WHOLE BUT NOT IN PART PURSUANT TO SECTION 2.06(a)
OF THE INDENTURE, (III) THIS GLOBAL NOTE MAY BE DELIVERED TO THE TRUSTEE FOR
CANCELLATION PURSUANT TO SECTION 2.11 OF THE INDENTURE AND (IV) THIS
GLOBAL NOTE MAY BE TRANSFERRED TO A SUCCESSOR DEPOSITARY WITH THE PRIOR WRITTEN
CONSENT OF THE COMPANY.

 

CUSIP 45031UAP6

 

5.125% Senior Notes due 2011

 

	
  No. 001

  	
  $245,000,000

  

 

iSTAR FINANCIAL INC.

 

promises to pay to CEDE & CO., or registered
assigns, the principal sum of TWO HUNDRED FORTY FIVE MILLION Dollars on April 1,
2011.

 

Interest Payment Dates:  April 1
and October1

 

Record Dates:  March15 and September 15

 

Dated:  August 13, 2004

 

	
   

  	
  iSTAR
  FINANCIAL INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
   

  	
  Name:

  
	
   

  	
   

  	
  Title:

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
   

  	
  Name:

  
	
   

  	
   

  	
  Title:

  

 

SEAL

 

This is one of the Notes referred to

in the within-mentioned Indenture:

 

	
  U.S. BANK TRUST NATIONAL ASSOCIATION

  as Trustee

  
	
   

  
	
   

  
	
  By:

  	
   

  	
   

  
	
   

  	
  Authorized Signatory

  	
   

  

 

 

A-1

 

[Back of Note]

5.125% Senior Notes due 2011

 

Capitalized terms used
herein shall have the meanings assigned to them in the Indenture referred to
below unless otherwise indicated.

 

1.  INTEREST.  iStar Financial Inc., a Maryland corporation
(the “Company”), promises to pay interest on
the principal amount of this Note at 5.125% per annum from March 30, 2004
until maturity.  The Company will pay
interest semi-annually in arrears on April 1 and October 1 of each
year, or if any such day is not a Business Day, on the next succeeding Business
Day (each an “Interest Payment Date”).  Interest on the Notes will accrue from the
most recent date to which interest has been paid or, if no interest has been
paid, from March 30, 2004; provided that
if there is no existing Default in the payment of interest, and if this Note is
authenticated between a record date referred to on the face hereof and the next
succeeding Interest Payment Date, interest shall accrue from such next
succeeding Interest Payment Date; provided, further, that the first Interest Payment Date shall be October 1,
2004.  The Company shall pay interest
(including post-petition interest in any proceeding under any Bankruptcy Law) on
overdue principal and premium, if any, from time to time on demand at the rate
then in effect; it shall pay interest (including post-petition interest in any
proceeding under any Bankruptcy Law) on overdue installments of interest
(without regard to any applicable grace periods) from time to time on demand at
the same rate to the extent lawful. 
Interest will be computed on the basis of a 360-day year of twelve
30-day months.

 

2.  METHOD OF PAYMENT.  The Company will pay interest on the Notes
(except defaulted interest) to the Persons who are registered Holders of Notes
at the close of business on the March 15 and September 15 next
preceding the Interest Payment Date, even if such Notes are canceled after such
record date and on or before such Interest Payment Date, except as provided in Section 2.12
of the Indenture with respect to defaulted interest.  The Notes will be payable as to principal,
premium, if any, and interest at the office or agency of the Company maintained
for such purpose within or without the City and State of New York, or, at the
option of the Company, payment of interest may be made by check mailed to the
Holders at their addresses set forth in the register of Holders, and provided that payment by wire transfer of immediately available
funds will be required with respect to principal of and interest, and premium,
if any, on, all Global Notes and all other Notes the Holders of which shall
have provided wire transfer instructions to the Company or the Paying
Agent.  Such payment shall be in such
coin or currency of the United States of America as at the time of payment is
legal tender for payment of public and private debts.  The Company reserves the right to pay
interest to Holders of Notes by check mailed to such Holders at their registered
addresses or by wire transfer to Holders of at least $5 million aggregate
principal amount of Notes.

 

3.  PAYING AGENT AND REGISTRAR.  Initially, U.S. Bank Trust National
Association, the Trustee under the Indenture, will act as Paying Agent and
Registrar.  The Company may change any
Paying Agent or Registrar without notice to any Holder.  The Company or any of its Subsidiaries may
act in any such capacity.

 

4.  INDENTURE.  The Company issued the Notes under an
Indenture dated as of March 30, 2004 (the “Indenture”)
between the Company and the Trustee.  The
terms of the Notes include those stated in the Indenture and those made part of
the Indenture by reference to the Trust Indenture Act of 1939, as amended (15
U.S. Code §§ 77aaa-77bbbb).  The
Notes are subject to all such terms, and Holders are referred to the Indenture
and such Act for a statement of such terms. 
To the extent any provision of this Note conflicts with the express
provisions of the Indenture, the provisions of the Indenture shall govern and
be controlling.  The Notes are obligations
of the Company.  The Company is issuing
$250.0 million in aggregate principal amount on the Issue Date and may issue
Additional Notes in accordance with the terms of the Indenture.

 

A-2

 

5.  OPTIONAL REDEMPTION.

 

At any time on or prior
to April 1, 2011, the Notes may be redeemed or purchased in whole but not
in part at the Company’s option at a price equal to 100% of the principal
amount thereof plus the Applicable Premium as of, and accrued but unpaid
interest, if any, to, the date of redemption or purchase (the “Redemption Date”) (subject to the right of Holders of record
on the relevant record date to receive interest due on the relevant interest
payment date).  Such redemption or
purchase may be made upon notice mailed by first-class mail to each Holder’s
registered address, not less than 30 nor more than 60 days prior to the
Redemption Date.

 

“Applicable
Premium” means, with respect to a Note at any Redemption Date, the
greater of:  (1) 1.0% of the
principal amount of such Note; and (2) the excess of (a) the present value
at such Redemption Date of (i) the redemption price of such Note on April 1,
2011 plus (ii) all required remaining scheduled interest payments due on
such Note through April 1, 2011, computed using a discount rate equal to
the Treasury Rate plus 50 basis points; over (b) the principal amount of
such Note on such Redemption Date. 
Calculation of the Applicable Premium will be made by the Company or on
behalf of the Company by such Person as the Company shall designate; provided, however, that
such calculation shall not be a duty or obligation of the Trustee.

 

“Treasury
Rate” means, with respect to a Redemption Date, the yield to
maturity at the time of computation of United States Treasury securities with a
constant maturity (as compiled and published in the most recent Federal Reserve
Statistical Release H.15(519) that has become publicly available at least
two Business Days prior to such Redemption Date (or, if such Statistical
Release is no longer published, any publicly available source of similar market
data)) most nearly equal to the period from such Redemption Date to April 1,
2011; provided, however,
that if the period from such Redemption Date to April 1, 2011 is not equal
to the constant maturity of the United States Treasury security for which a
weekly average yield is given, the Treasury Rate shall be obtained by linear
interpolation (calculated to the nearest one-twelfth of a year) from the weekly
average yields of United States Treasury securities for which such yields are
given, except that if the period from such Redemption Date to April 1,
2011 is less than one year, the weekly average yield on actually traded United
States Treasury securities adjusted to a constant maturity of one year shall be
used.

 

6.  MANDATORY REDEMPTION.

 

Except as set forth in
paragraph 7 below, the Company shall not be required to make mandatory redemption
payments with respect to the Notes.

 

7.  REPURCHASE AT OPTION OF
HOLDER.

 

Upon the occurrence of a
Change of Control, the Company will be required to offer to purchase all of the
outstanding Notes at a purchase price equal to 101% of the principal amount
thereof, plus accrued and unpaid interest, if any, thereon to the date of
repurchase.

 

8.  NOTICE OF REDEMPTION.  Notice of redemption will be mailed at least
30 days but not more than 60 days before the redemption date to each Holder
whose Notes are to be redeemed at its registered address.  Notes in denominations larger than $1,000 may
be redeemed in part but only in whole multiples of $1,000, unless all of the
Notes held by a Holder are to be redeemed. 
On and after the redemption date interest ceases to accrue on Notes or
portions thereof called for redemption.

 

9.  DENOMINATIONS, TRANSFER,
EXCHANGE.  The Notes are in
registered form without coupons in denominations of $1,000 and integral
multiples of $1,000.  The transfer of
Notes may be

 

A-3

 

registered and Notes
may be exchanged as provided in the Indenture. 
The Registrar and the Trustee may require a Holder, among other things,
to furnish appropriate endorsements and transfer documents and the Company and
the Trustee may require a Holder to pay any taxes and fees required by law or
permitted by the Indenture.  The Company
need not exchange or register the transfer of any Note or portion of a Note
selected for redemption, except for the unredeemed portion of any Note being
redeemed in part.  Also, the Company need
not exchange or register the transfer of any Notes for a period of 15 days
before a selection of Notes to be redeemed or during the period between a
record date and the corresponding Interest Payment Date.

 

10.  PERSONS DEEMED OWNERS.  The registered Holder of a Note may be
treated as its owner for all purposes.

 

11.  AMENDMENT, SUPPLEMENT AND
WAIVER.  Subject to certain
exceptions, the Indenture or the Notes may be amended or supplemented with the
written consent of the Holders of at least a majority in principal amount of
the then outstanding Notes voting as a single class, and any existing default
or compliance with any provision of the Indenture or the Notes may be waived
with the written consent of the Holders of a majority in principal amount of
the then outstanding Notes voting as a single class.  Without the consent of any Holder of a Note,
the Indenture or the Notes may be amended or supplemented to cure any
ambiguity, defect or inconsistency, to provide for uncertificated Notes in
addition to or in place of certificated Notes, to provide for the assumption of
the Company’s obligations to Holders of the Notes in case of a merger or
consolidation, to make any change that would provide any additional rights or
benefits to the Holders of the Notes or that does not adversely affect in any
material respects the rights under the Indenture of any such Holder, to comply
with the requirements of the SEC in order to effect or maintain the
qualification of the Indenture under the Trust Indenture Act or to evidence and
provide for the acceptance of appointment under the Indenture of a successor
Trustee.

 

12.  DEFAULTS AND REMEDIES.  Events of Default are set forth in the
Indenture.  If any Event of Default
occurs and is continuing, the Trustee or the Holders of at least 25% in principal
amount of the then outstanding Notes may declare all the Notes to be due and
payable.  Notwithstanding the foregoing,
in the case of an Event of Default arising from certain events of bankruptcy or
insolvency, all outstanding Notes will become due and payable without further
action or notice.  Holders may not
enforce the Indenture or the Notes except as provided in the Indenture.  Subject to certain limitations, Holders of a
majority in principal amount of the then outstanding Notes may direct the
Trustee in writing in its exercise of any trust or power.  The Trustee may withhold from Holders of the
Notes notice of any continuing Default or Event of Default (except a Default or
Event of Default relating to the payment of principal or interest) if it
determines that withholding notice is in their interest.  The Holders of a majority in aggregate
principal amount of the Notes then outstanding by written notice to the Trustee
may on behalf of the Holders of all of the Notes waive any existing Default or
Event of Default and its consequences under the Indenture except a continuing
Default or Event of Default in the payment of interest on, or the principal of,
the Notes.  The Company is required to
deliver to the Trustee annually a statement regarding compliance with the
Indenture, and the Company is required upon becoming aware of any Default or
Event of Default, to deliver to the Trustee a statement specifying such Default
or Event of Default.

 

13.  TRUSTEE DEALINGS WITH
COMPANY.  The Trustee, in its
individual or any other capacity, may make loans to, accept deposits from, and
perform services for the Company or its Affiliates, and may otherwise deal with
the Company or its Affiliates, as if it were not the Trustee.

 

14.  NO RECOURSE AGAINST OTHERS.  A director, officer, employee, incorporator
or stockholder, of the Company, as such, shall not have any liability for any
obligations of the Company under the Notes or the Indenture or for any claim
based on, in respect of, or by reason of, such obligations

 

A-4

 

or their
creation.  Each Holder by accepting a
Note waives and releases all such liability. 
The waiver and release are part of the consideration for the issuance of
the Notes.

 

15.  AUTHENTICATION.  This Note shall not be valid until
authenticated by the manual signature of the Trustee or an authenticating
agent.

 

16.  ABBREVIATIONS.  Customary abbreviations may be used in the
name of a Holder or an assignee, such as: 
TEN COM (= tenants in common), TEN ENT (= tenants by the entireties), JT
TEN (= joint tenants with right of survivorship and not as tenants in common),
CUST (= Custodian), and U/G/M/A (= Uniform Gifts to Minors Act).

 

17.  CUSIP NUMBERS.  Pursuant to a recommendation promulgated by
the Committee on Uniform Security Identification Procedures, the Company has
caused CUSIP numbers to be printed on the Notes and the Trustee may use CUSIP
numbers in notices of redemption as a convenience to Holders.  No representation is made as to the accuracy
of such numbers either as printed on the Notes or as contained in any notice of
redemption and reliance may be placed only on the other identification numbers
placed thereon.

 

A-5

 

The Company will furnish
to any Holder upon written request and without charge a copy of the Indenture.  Requests may be made to:

 

iStar Financial Inc.

1114 Avenue of the Americas, 27th Floor

New York, NY  10036

Attention:  Investor Relations

 

A-6

 

ASSIGNMENT FORM

 

To assign this Note, fill
in the form below:

 

	
  (I) or (we) assign and transfer this Note to: 

  	
   

  
	
  (Insert assignee’s legal name)

  
	
   

  
	
   

  
	
  (Insert assignee’s soc. sec. or tax I.D. no.)

  
	
   

  
	
   

  
	
   

  
	
   

  
	
   

  
	
   

  
	
  (Print or type assignee’s name, address and zip
  code)

  
	
   

  
	
  and irrevocably appoint

  	
   

  
	
  to transfer this Note on the books of the Company.
  The agent may substitute another to act for him.

  
	
   

  
	
  Date: 

  	
   

  	
   

  
	
   

  
	
   

  	
  Your
  Signature:

  	
   

  
	
   

  	
   

  	
  (Sign
  exactly as your name appears on the face of this Note)

  
	
   

  
	
  Signature Guarantee*:

  	
   

  	
   

  
							

 

*                                         Participant
in a recognized Signature Guarantee Medallion Program (or other signature
guarantor acceptable to the Trustee).

 

A-7

 

OPTION OF HOLDER TO ELECT PURCHASE

 

If you want to elect to
have this Note purchased by the Company pursuant to Section 4.13 of the
Indenture, check the following box :  o

 

If you want to elect to
have only part of the Note purchased by the Company pursuant to Section 4.13
of the Indenture, state the amount you elect to have purchased:

 

$                    

 

	
  Date:

  	
   

  	
   

  
	
   

  
	
   

  	
   

  	
   

  	
  Your
  Signature:

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
  (Sign
  exactly as your name appears on the face of this Note)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
  Tax
  Identification No.:

  	
   

  
	
   

  
	
  Signature Guarantee*:

  	
   

  	
   

  
									

 

*                                         Participant
in a recognized Signature Guarantee Medallion Program (or other signature
guarantor acceptable to the Trustee).

 

A-8

 

SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL NOTE

 

The following exchanges
of a part of this Global Note for an interest in another Global Note or for a
Definitive Note, or exchanges of a part of another Global Note or Definitive
Note for an interest in this Global Note, have been made:

 

	
  Date of Exchange

  	
   

  	
  Amount of

  decrease in

  Principal Amount

  of this Global

  Note

  	
   

  	
  Amount of

  increase in

  Principal Amount

  of this Global

  Note

  	
   

  	
  Principal Amount

  of this Global

  Note following

  such decrease

  (or increase)

  	
   

  	
  Signature of

  authorized officer

  of Trustee or

  Note Custodian

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  

 

A-9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00080-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00080-of-00352.parquet"}]]